Annual report [Section 13 and 15(d), not S-K Item 405]
Cover
Document and Entity Information
Financial Statements
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS (Parenthetical)
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Notes to Financial Statements
Description of Business
Basis of Presentation and Significant Accounting Policies
Consolidated Financial Statements Details
Licensing and Other Arrangements
Royalty and Commercial Payment Purchase Agreements
Fair Value Measurements
Lease Agreements
Long-Term Debt
Income Taxes
Stock Based Compensation and Other Benefit Plans
Net Loss Per Share Attributable to Common Stockholders
Capital Stock
Commitments and Contingencies
Segment and Geographic Information
Subsequent Events
Pay vs Performance Disclosure
Insider Trading Arrangements
Insider Trading Policies and Procedures
Cybersecurity Risk Management and Strategy Disclosure
Accounting Policies
Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Basis of Presentation and Significant Accounting Policies (Tables)
Consolidated Financial Statements Details (Tables)
Acquisitions, Licensing and Other Arrangements (Tables)
Royalty and Commercial Payment Purchase Agreements (Tables)
Fair Value Measurements (Tables)
Lease Agreements (Tables)
Long-Term Debt (Tables)
Income Taxes (Tables)
Stock Based Compensation and Other Benefit Plans (Tables)
Net Loss Per Share Attributable to Common Stockholders (Tables)
Capital Stock (Tables)
Segment and Geographic Information (Tables)
Notes Details
Description of Business - Liquidity (Details)
Basis of Presentation and Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)
Basis of Presentation and Significant Accounting Policies - Concentration of Risk (Details)
Basis of Presentation and Significant Accounting Policies - Purchase of Rights to Future Milestones, Royalties, and Commercial Payments (Details)
Basis of Presentation and Significant Accounting Policies - Income Taxes and Share Repurchases (Details)
Basis of Presentation and Significant Accounting Policies - Reclassifications (Details)
Consolidated Financial Statements Details - Equity Securities (Details)
Consolidated Financial Statements Details - Intangible Assets, Net (Details)
Consolidated Financial Statements Details - Accrued and Other Liabilities (Details)
Consolidated Financial Statements Details - Arbitration Proceeding (Details)
Acquisitions, Licensing and Other Arrangements - Pulmokine Acquisition (Details)
Acquisitions, Licensing and Other Arrangements - Kinnate Acquisition (Details)
Acquisitions, Licensing and Other Arrangements - Alexion (Details)
Acquisitions, Licensing and Other Arrangements - Takeda (Details)
Acquisitions, Licensing and Other Arrangements - Rezolute (Details)
Acquisitions, Licensing and Other Arrangements - Janssen (Details)
Acquisitions, Licensing and Other Arrangements - ObsEva (Details)
Acquisitions, Licensing and Other Arrangements - Sale of Future Revenue Streams (Details)
Royalty and Commercial Payment Purchase Agreements - Fully Recovered - Viracta (Details)
Royalty and Commercial Payment Purchase Agreements - Under EIR Method (Details)
Royalty and Commercial Payment Purchase Agreements - EIR Method - Affitech (Details)
Royalty and Commercial Payment Purchase Agreements - EIR Method - Aptevo (Details)
Royalty and Commercial Payment Purchase Agreements - Under Cost Recovery Method (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Twist Bioscience (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Dare (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - LadRx (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Palobiofarma (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Kuros (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Agenus (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Aronora (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Talphera (Details)
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Bioasis (Details)
Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details)
Fair Value Measurements - Financial Assets and Liabilities Carried at FV on Recurring Basis and Exarafenib Milestone Contingent Consideration (Details)
Fair Value Measurements - Milestone Asset and Milestone Contingent Consideration (Details)
Fair Value Measurements - Contingent Consideration (Details)
Lease Agreements - Leased facilities (Details)
Lease Agreements - Maturity of lease liabilities (Details)
Lease Agreements - Lease costs (Details)
Lease Agreements - Additional information (Details)
Long-Term Debt - Agreement (Details)
Long-Term Debt - Balance (Details)
Long-Term Debt - Aggregate projected future principal and discounts (Details)
Long-Term Debt - Interest expense (Details)
Income Taxes - Provision for Income Taxes (Details)
Income Taxes - Reconciliation between statutory rate and effective rate (Details)
Income Taxes - Components of Net Deferred Tax Assets (Details)
Income Taxes - NOL (Details)
Income Taxes - Tax credit carryforward (Details)
Income Taxes - Unrecognized Tax Benefits (Details)
Stock Based Compensation and Other Benefit Plans - ESPP (Details)
Stock Based Compensation and Other Benefit Plans - Deferred Savings Plan (Details)
Stock Based Compensation - 2010 Plan Stock Options (Details)
Stock Based Compensation - FV Assumptions 2010 Plan Stock Options (Details)
Stock Based Compensation and Other Benefit Plans - Stock Option Inducement Awards (Details)
Stock Based Compensation and Other Benefit Plans - Stock Option Activity (Details)
Stock Based Compensation and Other Benefit Plans - Performance Stock Unit Awards (Details)
Stock Based Compensation and Other Benefit Plans - Performance Stock Unit Awards Fair Value (Details)
Stock Based Compensation and Other Benefit Plans - Performance Stock Unit Awards Activity (Details)
Stock Based Compensation - Restricted Stock Unit Awards (Details)
Stock Based Compensation and Other Benefit Plans - Stock-based Compensation Expense (Details)
Net Loss Per Share Attributable to Common Stockholders - Outstanding Securities Considered Anti-Dilutive (Details)
Net Loss Per Share Attributable to Common Stockholders - Reconciliation of Numerator and Denominator Used in Calculation of EPS (Details)
Capital Stock - Series X Convertible Preferred Stock (Details)
Capital Stock - Series A Preferred Stock (Details)
Capital Stock - Depositary Shares Representing Interest in Series B Preferred Stock (Details)
Capital Stock - Dividends (Details)
Capital Stock - BVF Ownership (Details)
Capital Stock - ATM Agreements (Details)
Capital Stock - Summary of Common Stock Warrants Outstanding (Details)
Capital Stock - Common Stock Warrants (Details)
Capital Stock - Weighted average assumptions (Details)
Commitments and Contingencies - Collaborative Agreements, Royalties and Milestone Payments (Details)
Commitments and Contingencies - Contingent Consideration (Details)
Segment and Geographic Information - Segment Information (Details)
Segment and Geographic Information - Geographic Regions (Details)
Subsequent Events (Details)
Capital Stock - Depositary Shares Representing Interest in Series B Preferred Stock (Details)
403 Forbidden
Forbidden
You don't have permission to access this resource.